Premium
Letter: CYP2C19 polymorphisms and exacerbation of rabeprazole's effects on celecoxib‐induced small bowel injury—authors' reply
Author(s) -
Nuki Y.,
Esaki M.
Publication year - 2017
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.14264
Subject(s) - rabeprazole , cyp2c19 , celecoxib , medicine , pharmacology , gastroenterology , genotype , omeprazole , cyp2c9 , pharmacogenetics , chemistry , cytochrome p450 , biochemistry , gene , metabolism